| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A bit of sweetness for GVHD prevention
|
Mohty, Mohamad
|
|
|
125 |
9 |
p. 1364-1365
|
artikel
|
| 2 |
Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor
|
Puy, Cristina
|
|
|
125 |
9 |
p. 1488-1496
|
artikel
|
| 3 |
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
|
Lindsley, R. Coleman
|
|
|
125 |
9 |
p. 1367-1376
|
artikel
|
| 4 |
A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice
|
Sepulveda, Fernando E.
|
|
|
125 |
9 |
p. 1427-1434
|
artikel
|
| 5 |
Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease
|
Harrison, Christine J.
|
|
|
125 |
9 |
p. 1383-1386
|
artikel
|
| 6 |
Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression
|
Jacobsen, Eric D.
|
|
|
125 |
9 |
p. 1394-1402
|
artikel
|
| 7 |
CD30: seeing is not always believing
|
Blum, Kristie A.
|
|
|
125 |
9 |
p. 1358-1359
|
artikel
|
| 8 |
Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation
|
Dargaud, Yesim
|
|
|
125 |
9 |
p. 1497-1501
|
artikel
|
| 9 |
Compound loss of function of nuclear receptors Tr2 and Tr4 leads to induction of murine embryonic β-type globin genes
|
Cui, Shuaiying
|
|
|
125 |
9 |
p. 1477-1487
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
125 |
9 |
p. i
|
artikel
|
| 11 |
Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma
|
Huang, Yuanshen
|
|
|
125 |
9 |
p. 1435-1443
|
artikel
|
| 12 |
Ex vivo fucosylation of third-party human regulatory T cells enhances anti–graft-versus-host disease potency in vivo
|
Parmar, Simrit
|
|
|
125 |
9 |
p. 1502-1506
|
artikel
|
| 13 |
How I use fibrinogen replacement therapy in acquired bleeding
|
Levy, Jerrold H.
|
|
|
125 |
9 |
p. 1387-1393
|
artikel
|
| 14 |
IRF8 acts in lineage-committed rather than oligopotent progenitors to control neutrophil vs monocyte production
|
Yáñez, Alberto
|
|
|
125 |
9 |
p. 1452-1459
|
artikel
|
| 15 |
Janus kinase inhibition by ruxolitinib extends dasatinib- and dexamethasone-induced remissions in a mouse model of Ph+ ALL
|
Appelmann, Iris
|
|
|
125 |
9 |
p. 1444-1451
|
artikel
|
| 16 |
Malignant TOXication of T cells
|
Odum, Niels
|
|
|
125 |
9 |
p. 1361-1362
|
artikel
|
| 17 |
Notch1 acts via Foxc2 to promote definitive hematopoiesis via effects on hemogenic endothelium
|
Jang, Il Ho
|
|
|
125 |
9 |
p. 1418-1426
|
artikel
|
| 18 |
Platelet hyaluronidase-2: an enzyme that translocates to the surface upon activation to function in extracellular matrix degradation
|
Albeiroti, Sami
|
|
|
125 |
9 |
p. 1460-1469
|
artikel
|
| 19 |
Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality
|
Goel, Ruchika
|
|
|
125 |
9 |
p. 1470-1476
|
artikel
|
| 20 |
Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results
|
Leleu, Xavier
|
|
|
125 |
9 |
p. 1411-1417
|
artikel
|
| 21 |
Ribosomopathies and the paradox of cellular hypo- to hyperproliferation
|
De Keersmaecker, Kim
|
|
|
125 |
9 |
p. 1377-1382
|
artikel
|
| 22 |
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma
|
Omuro, Antonio
|
|
|
125 |
9 |
p. 1403-1410
|
artikel
|
| 23 |
Targeting BCR-ABL and JAK2 in Ph+ ALL
|
Hantschel, Oliver
|
|
|
125 |
9 |
p. 1362-1363
|
artikel
|
| 24 |
Treatment of primary CNS lymphoma
|
Schmitz, Norbert
|
|
|
125 |
9 |
p. 1360-1361
|
artikel
|
| 25 |
Unwelcome passengers
|
Rashidi, Armin
|
|
|
125 |
9 |
p. 1507
|
artikel
|
| 26 |
What came first: MDS or AML?
|
Walter, Matthew J.
|
|
|
125 |
9 |
p. 1357-1358
|
artikel
|
Tijdschrift beschrijving